<Nav.Linkas={Link}to="section1"smooth={true}duration={500}className={activeLink==='section1'?'active':'notActive'}>ODE Model of Biochemical Reactions</Nav.Link>
<Nav.Linkas={Link}to="section2"smooth={true}duration={500}className={activeLink==='section2'?'active':'notActive'}>Metabolic Engineering Strategy to Reduce Ammonia Production</Nav.Link>
<p>The Michaelis-Menten mechanism describes the enzymatic conversion of a substrate <MathJax.Provider>
<span>
...
...
@@ -190,8 +187,7 @@ export function Model() {
<MathJax.Provider>
<divclassName='indent formula_content'>
<spanclassName='formula_line'><MathJax.Nodeformula={`{{E+S}\\overset{k_{f1}}{\\underset{k_{r1}}{\\rightleftharpoons}} ES \\xrightarrow[]{k_{cat}}E + P}`}/></span>
<p>The FeaR-phenylacetaldehyde complex can bind and activate the PTynA promoter. In this case, the concentration of the enzyme-substrate complex <MathJax.Provider>
<p>For an enzyme-catalyzed reaction involving two substrates that form a single product, the Michaelis-Menten equation can be extended to account for the involvement of both substrates. The general reaction can be written as</p>
<p>TPH1 converts tryptophan that enters the cytoplasm into 5-hydroxytryptophan, which is then transported from the cytoplasm into the gut. The corresponding reaction equations and ODEs are as follows</p>
<p>In summary, our metabolic engineering analysis provided multiple knockout schemes, including single and multi-gene knockouts. Through gene knockout, ammonia production can be reduced to approximately <b>18% </b>of the wild-type levels, while the growth rate of the strain can be maintained at about <b>80%</b> of the wild-type. This finding offers significant directions for genetic modifications in the development of engineered strains intended for in vivo therapy.</p>
@@ -94,6 +94,7 @@ The next page details the security measures and considerations our team has take
<pclassName="indent">Additionally, we recognize that abdominal infections are a significant cause of recurrent hepatic encephalopathy and can lead to death. In response, we aim to develop an engineered bacterium capable of resisting inflammation and repairing the intestinal barrier. </p>
<pclassName="indent">Insights from discussions with the Peking University Medical School team have inspired our approach to utilizing curli fibers.And we referred to a study published in Nature Communications And the PATCH system was used for plasmid design. </p>
<pclassName="indent">In the end, the safety module we designed can effectively prevent and treat abdominal infection in patients with liver disease, solve intestinal flora disorders, support intestinal barrier function repair and alleviate complications of hepatic encephalopathy.</p>
<pclassName="indent">For details, you can see our safety module design section.</p>